TERLIPRESSIN IS ASSOCIATED WITH DECREASED HEALTHCARE RESOURCE UTILIZATION COMPARED WITH MIDODRINE/ OCTREOTIDE AMONG PATIENTS WITH HEPATORENAL SYNDROME

被引:0
|
作者
DeSousa, Alexandra [1 ]
Goyal, Tanvi [1 ]
Kaplan, David [1 ]
Nahas, Jonathan [1 ]
机构
[1] Univ Penn, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1740
引用
收藏
页数:1
相关论文
共 50 条
  • [1] TERLIPRESSIN VERSUS MIDODRINE/OCTREOTIDE FOR HEPATORENAL SYNDROME
    Juang, Paul
    Yeary, Julianne
    Barker, Skyler
    Owen, Emily
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [2] Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1
    Kalambokis, Georgios N.
    Baltayiannis, Gerasimos
    Christodoulou, Dimitrios
    Christou, Leonidas
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (12) : 1428 - 1429
  • [3] EVALUATION AND OUTCOMES OF MIDODRINE, OCTREOTIDE, AND ALBUMIN IN PATIENTS WITH HEPATORENAL SYNDROME
    Patel, Jignesh
    Tran, Michelle
    Trujillo, Nalea
    Mata, Kenneth
    Chan, Patrick
    CRITICAL CARE MEDICINE, 2024, 52
  • [4] Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
    Cavallin, Marta
    Kamath, Patrick S.
    Merli, Manuela
    Fasolato, Silvano
    Toniutto, Pierluigi
    Salerno, Francesco
    Bernardi, Mauro
    Romanelli, Roberto Giulio
    Colletta, Cosimo
    Salinas, Freddy
    Di Giacomo, Antonio
    Ridola, Lorenzo
    Fornasiere, Ezio
    Caraceni, Paolo
    Morando, Filippo
    Piano, Salvatore
    Gatta, Angelo
    Angeli, Paolo
    HEPATOLOGY, 2015, 62 (02) : 567 - 574
  • [5] Does Midodrine and Octreotide Truly Improve Survival in Cirrhotic Patients with Hepatorenal Syndrome?
    Gonzalez, Humberto
    Sharma, Rishi
    Huang, Mary Ann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S154 - S154
  • [6] Early diagnosis and treatment with Terlipressin for adults with hepatorenal syndrome improves clinical outcomes and reduces healthcare resource utilization
    Gallegos-Orozco, Juan F.
    O'Leary, Jacqueline G.
    Reddy, Gautham
    Jamil, Khurram
    Bindra, Jas
    Chopra, Ishveen
    Niewoehner, John
    Huang, Xingyue
    JOURNAL OF HEPATOLOGY, 2024, 80 : S118 - S119
  • [7] Combination of Terlipressin and Albumin versus Combination of Midodrine, Octreotide, and Albumin in Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
    Karki, Bhesh R.
    Shrestha, Dhan B.
    Budhathoki, Pravash
    Sedhai, Yub Raj
    Dahal, Sanju
    Gautam, Anu
    Shukla, Samikshya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S528 - S529
  • [8] Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
    Wong, F
    Pantea, L
    Sniderman, K
    HEPATOLOGY, 2004, 40 (01) : 55 - 64
  • [9] Noradrenalin Versus the Combination of Midodrine and Octreotide in Patients with Hepatorenal Syndrome: Randomized Clinical Trial
    Tavakkoli, Hamid
    Yazdanpanah, Kambiz
    Mansourian, Marjan
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (11) : 764 - 769
  • [10] Terlipressin vs Midodrine Plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison
    Gonzalez, Stevan A.
    Chirikov, Viktor V.
    Wang, Wei-Jhih
    Huang, Xingyue
    Jamil, Khurram
    Simonetto, Douglas A.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (12)